Prosecution Insights
Prosecution Insights
Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Jilin Venus Haoyue Medical Limited has 1 pending office action in the Chemistry & Materials technology area. The prosecution activity is currently restricted to 1 distinct examiner and 1 distinct art unit. This suggests a very specific and narrow engagement with the patent office for the company's active applications. The absence of multiple pending actions across different units indicates that the company is currently focusing its resources on a single patenting effort within the chemistry sector. This concentration allows for a highly specialized legal approach tailored to the specific standards of the assigned art unit.
KATHERINE A BAREFORD is the busiest examiner for this portfolio, managing 1 pending office action. With 1 pending matter assigned to this examiner, the company's immediate success in the patent process is dependent on the specific feedback from this individual. This concentration of the workload allows for a focused legal approach but relies entirely on the outcome of a single examination process. Navigating the 1 pending office action will require a detailed response that aligns with the examiner's specific technical expectations in Chemistry & Materials. The prosecution progress is currently consolidated within this single administrative channel.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BAREFORD, KATHERINE A | 1 | 13.8% | +28.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18211274 | LONG-ACTING SUPERHYDROPHOBIC ANTICOAGULATION BIOLOGICAL VALVE AND PREPARATION METHOD THEREFOR | BAREFORD, KATHERINE A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18211274 | LONG-ACTING SUPERHYDROPHOBIC ANTICOAGULATION BIOLOGICAL VALVE AND PREPARATION METHOD THEREFOR | BAREFORD, KATHERINE A | — |
| Art Unit | Apps |
|---|---|
| 1786 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18211274 | LONG-ACTING SUPERHYDROPHOBIC ANTICOAGULATION BIOLOGICAL VALVE AND PREPARATION METHOD THEREFOR | BAREFORD, KATHERINE A | 1786 | §103§112 | Non-Final OA | — | Pending | Jun 18, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial